← Back to Discover
BIOS Capital Management, LP
Period ended Sep 30, 2026 · Latest filing Nov 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $34,170,550
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- OPUS GENETICS INC · COM · 67577R102 · shares: $17,827,796
- ACTUATE THERAPEUTICS INC · COM · 005083100 · shares: $7,838,997
- COGNITION THERAPEUTICS INC · COM · 19243B102 · shares: $5,760,000
- REIN THERAPEUTICS INC · COM NEW · 00887A204 · shares: $2,397,830
- LANTERN PHARMA INC · COM · 51654W101 · shares: $238,254
- IN8BIO INC · COM NEW · 45674E208 · shares: $107,673
Reported holdings
9 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| OPUS GENETICS INC | COM | 67577R102 | — | 3,683,429 shares | $17,827,796 |
| ACTUATE THERAPEUTICS INC | COM | 005083100 | — | 8,594,141 shares | $6,703,430 |
| COGNITION THERAPEUTICS INC | COM | 19243B102 | — | 5,499,905 shares | $5,279,909 |
| REIN THERAPEUTICS INC | COM NEW | 00887A204 | — | 1,758,375 shares | $1,413,734 |
| ACTUATE THERAPEUTICS INC | COM | 005083100 | — | 1,455,855 shares | $1,135,567 |
| REIN THERAPEUTICS INC | COM NEW | 00887A204 | — | 1,224,000 shares | $984,096 |
| COGNITION THERAPEUTICS INC | COM | 19243B102 | — | 500,095 shares | $480,091 |
| LANTERN PHARMA INC | COM | 51654W101 | — | 235,895 shares | $238,254 |
| IN8BIO INC | COM NEW | 45674E208 | — | 80,957 shares | $107,673 |